Ulland Investment Advisors, LLC Pfizer Inc Transaction History

Ulland Investment Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 23, 2023	SELL	$32.09 - $37.51 $342,143 - $399,931	-10,662 Reduced 75.55%	3,450 $114,000
Q2 2023 Jul 20, 2023	SELL	$36.12 - $41.79 $64,835 - $75,013	-1,795 Reduced 11.28%	14,112 $518,000
Q1 2023 Apr 17, 2023	SELL	$39.39 - $51.28 $62,945 - $81,945	-1,598 Reduced 9.13%	15,907 $649,000
Q4 2022 Jan 31, 2023	BUY	$41.75 - $54.5 $147,586 - $192,657	3,535 Added 25.3%	17,505 $897,000
Q3 2022 Oct 12, 2022	SELL	$43.76 - $53.42 $35,008 - $42,736	-800 Reduced 5.42%	13,970 $611,000
Q2 2022 Jul 25, 2022	SELL	$46.53 - $55.17 $186,120 - $220,680	-4,000 Reduced 21.31%	14,770 $774,000
Q1 2022 May 09, 2022	SELL	$45.75 - $56.69 $15,555 - $19,274	-340 Reduced 1.78%	18,770 $972,000
Q4 2021 Feb 16, 2022	BUY	$41.32 - $61.25 $789,625 - $1.17 Million	19,110 New	19,110 $1.13 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Ulland Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ulland Investment Advisors, LLC with notifications on news.